2 Layers

Our purpose

To improve life during and beyond sedation

Sedana Medical is a pioneer medtech and pharmaceutical company dedicated to making inhaled sedation a standard therapy in intensive care.

More about us

Bringing inhaled sedation to intensive care

We are proud to introduce inhaled sedation to intensive care, a paradigm shift in the care of critically ill patients.

Through the results obtained in the pivotal study with Sedaconda (isoflurane) and Sedaconda ACD*, we have laid the foundation for inhaled sedation in intensive care.

By this, we have also taken a major step closer to our vision – to make inhaled sedation a standard therapy in intensive care.

*formerly known as AnaConDa

Learn more

Sedana Sedaconda Hand 02 (2)

Clinical Research

Our vision is for inhaled sedation to be a global standard therapy for patients in intensive care.

To achieve this, we will through clinical research pave the way for a paradigm shift in sedation in the intensive care.

Our research aims at a greater understanding of and increased knowledge about inhaled sedation, leading to medical advances for the benefit of patients in intensive care.

We also believe in working in partnerships – through various initiatives and research projects – that can lead to continued development and meaningful improvement for both patients and the healthcare system.

Learn More

Press Releases

Sedana Medical’s products receive MDR certification

Non-regulatory

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announces that the company has received Medica…

Sedana Medical AB Interim report January-June 2022

Regulatory

Committed to change the standard of care, with commercial progress and a strong balance sheet.

View All Press Releases

Our products

Explore our broad portfolio of products for the administration of inhaled anaesthetics.

Learn More

View All Products